Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04305795
Title An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rakuten Medical, Inc.
Indications

skin squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

ASP-1929 + Pembrolizumab

ASP-1929 + Cemiplimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.